Netflix can sustain its lofty valuation only if global subscriber growth can support increasing content spending and debt.Technologyread more
The company blamed its Q2 content slate and price increases for the subscriber miss.Technologyread more
IBM's year-over-year revenue has now declined for four quarters in a row. Impact from Red Hat is not yet factored into the company's guidance.Technologyread more
The House voted to table a resolution to start impeachment proceedings against President Donald Trump introduced by Rep. Al Green.Politicsread more
See which stocks are posting big moves after the bell on July 17.Market Insiderread more
"It's clearly doing more harm than good," the "Mad Money" host says. Instead Facebook should buy Square for $70 billion and expand the payments network worldwide.Mad Money with Jim Cramerread more
Silicon Valley workers say they gravitate toward Yang, who is running for president as a Democrat, because of his approach to research and understanding of tech's moral...Technologyread more
Prosecutors in Masschusetts have dropped a criminal case against actor Kevin Spacey, who had been accused of groping an 18-year-old man.Entertainmentread more
"The passport contains numerous ingress and egress stamps, including stamps that reflect use of the passport to enter France, Spain, the United Kingdom, and Saudi Arabia in...Politicsread more
Loup Ventures founder Gene Munster told CNBC's "Fast Money" on Wednesday that Netflix's disappointing second quarter results are a turning point for the company, saying the...Technologyread more
Corporate earnings forecasts for the second quarter were lowered so much that companies are easily beating them.Market Insiderread more
On today's Halftime Report value investor Jim Lebenthal discusses three names that he believes provides safety, are cheap, and give you yield.
Jim's first pick is Pfizer. Pfizer's stock has had a nice rally this year up 14%. Lebenthal believes in the pipeline; "In Pfizer's case you've got a great and growing oncology franchise."
Next up is Qualcomm, where the focus is China.
"In Qualcomm what you're looking for is what's going on in China.They started to sign up a lot of Chinese smart phone OEM's over the last several months," he said. He believes Qualcomm's dividend yield is a good safety net.
Last on Jim's list is Intel. He is bullish Intel believingthat they could be involved in the new iPhone 7.
"What's key for me is what's going on with them and the iPhone7. There is a lot of talk about them getting more and more contract wins that could propel the stock higher."
All three companies have low earnings multiples.
"If you want to be a little defensive and you don't want to chase those consumer staple stocks selling at 20 plus times earnings then these names whether it's Intel, Qualcomm, or Pfizer are all trading at relatively low multiples," said Lebenthal.
Trader disclosure: Jim Lebenthal owns INTC, QCOM, and PFE.